Role of Smoking in Global and Regional Cardiovascular Mortality

Background—Smoking is a major cause of cardiovascular disease mortality. There is little information on how it contributes to global and regional cause-specific mortality from cardiovascular diseases for which background risk varies because of other risks. Method and Results—We used data from the American Cancer Society’s Cancer Prevention Study II (CPS II) and the World Health Organization Global Burden of Disease mortality database to estimate smoking-attributable deaths from ischemic heart disease, cerebrovascular disease, and a cluster of other cardiovascular diseases for 14 epidemiological subregions of the world by age and sex. We used lung cancer mortality as an indirect marker for accumulated smoking hazard. CPS-II hazards were adjusted for important covariates. In the year 2000, an estimated 1.62 (95% CI, 1.27 to 2.04) million cardiovascular deaths in the world, 11% of total global cardiovascular deaths, were due to smoking. Of these, 1.17 million deaths were among men and 450 000 among women. There were 670 000 (95% CI, 440 000 to 920 000) smoking-attributable cardiovascular deaths in the developing world and 960 000 (95% CI, 770 000 to 1 200 000) in industrialized regions. Ischemic heart disease accounted for 54% of smoking-attributable cardiovascular mortality, followed by cerebrovascular disease (25%). There was variability across regions in the role of smoking as a cause of various cardiovascular diseases. Conclusions—More than 1 in every 10 cardiovascular deaths in the world in the year 2000 were attributable to smoking, demonstrating that it is an important preventable cause of cardiovascular mortality.

[1]  J. Lawson Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors , 2006 .

[2]  Rachel Leach,et al.  Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development , 2005, PLoS medicine.

[3]  M. Ezzati How can cross-country research on health risks strengthen interventions? Lessons from INTERHEART , 2004, The Lancet.

[4]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[5]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[6]  A. Lucas,et al.  Early origins of cardiovascular disease: is there a unifying hypothesis? , 2004, The Lancet.

[7]  R. Burnett,et al.  Cardiovascular Mortality and Long-Term Exposure to Particulate Air Pollution: Epidemiological Evidence of General Pathophysiological Pathways of Disease , 2003, Circulation.

[8]  Majid Ezzati,et al.  Estimates of global mortality attributable to smoking in 2000 , 2003, The Lancet.

[9]  R. Peto,et al.  Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43 000 adult male deaths and 35 000 controls , 2003, The Lancet.

[10]  Majid Ezzati,et al.  Estimates of global and regional potential health gains from reducing multiple major risk factors , 2003, The Lancet.

[11]  Guilbert Jj The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[12]  Alan D. Lopez,et al.  Measuring the accumulated hazards of smoking: global and regional estimates for 2000 , 2003, Tobacco control.

[13]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[14]  Prabhat Jha,et al.  Estimates of global and regional smoking prevalence in 1995, by age and sex. , 2002, American journal of public health.

[15]  B. Popkin The shift in stages of the nutrition transition in the developing world differs from past experiences! , 2002, Public health nutrition.

[16]  David Satcher,et al.  Women and smoking: a report of the Surgeon General. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[17]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[18]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[19]  R. Magnien State monitoring activities related to Pfiesteria-like organisms. , 2001, Environmental health perspectives.

[20]  K R Nielsen,et al.  Acute exposure to environmental tobacco smoke and heart rate variability. , 2001, Environmental health perspectives.

[21]  M. Thun,et al.  Methodological issues in estimating smoking-attributable mortality in the United States. , 2000, American journal of epidemiology.

[22]  M. Thun,et al.  Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. , 2000, JAMA.

[23]  K. Juel,et al.  Estimating mortality due to cigarette smoking: two methods, same result. , 2000, Epidemiology.

[24]  L. Appel,et al.  Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. , 1999, JAMA.

[25]  R. Peto,et al.  Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths , 1998, BMJ.

[26]  D. Pelletier,et al.  Trends in Body Mass Index in Developing Countries , 1998 .

[27]  J. Mindell Tobacco or health: a global status report. , 1998 .

[28]  H Schultz,et al.  Tobacco or health: A global status report. , 1998, Annals of Saudi medicine.

[29]  N J Wald,et al.  Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence , 1997, BMJ.

[30]  N J Wald,et al.  The accumulated evidence on lung cancer and environmental tobacco smoke , 1997, BMJ.

[31]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[32]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[33]  S. Glantz,et al.  Passive smoking and heart disease. Mechanisms and risk. , 1995 .

[34]  R Doll,et al.  Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.

[35]  R. Doll,et al.  Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors , 1994, BMJ.

[36]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[37]  R. Mulcahy The health benefits of smoking cessation. , 1990, Irish medical journal.

[38]  L. Garfinkel Selection, follow-up, and analysis in the American Cancer Society prospective studies. , 1985, National Cancer Institute monograph.

[39]  S. Greenland Bias in methods for deriving standardized morbidity ratio and attributable fraction estimates. , 1984, Statistics in medicine.

[40]  R D Rudolf,et al.  High Blood Pressure , 1937, Canadian Medical Association journal.

[41]  Majid Ezzati,et al.  Smoking and oral tobacco use , 2004 .

[42]  Office on Smoking The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[43]  Alan D. Lopez,et al.  Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. Volume 1. , 2004 .

[44]  M. Winniford,et al.  Cigarette smoking increases sympathetic outflow in humans. , 1998, Circulation.

[45]  K Steenland,et al.  Passive smoking and the risk of heart disease. , 1992, JAMA.

[46]  G. Johnson,et al.  Lead exposure. , 1992, The Western journal of medicine.

[47]  Max Henrion,et al.  Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis , 1990 .

[48]  R. Peto Influence of dose and duration of smoking on lung cancer rates. , 1986, IARC scientific publications.

[49]  D. Zaridze,et al.  TOBACCO: A MAJOR INTERNATIONAL HEALTH HAZARD , 1986 .

[50]  D. Burkitt Chapter 9 – Diseases of Affluence , 1980 .

[51]  J. Higginson,et al.  International Agency for Research on Cancer. , 1968, WHO chronicle.